# EDGAR Filing Document

**Accession Number:** 0000932021
**File Stem:** 0001641172-25-013617
**Filing Date:** 2025-6
**Character Count:** 9827
**Document Hash:** f68c9c98f35dbbfa1f99302f3475f2a9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-013617.hdr.sgml**: 20250604

**ACCESSION NUMBER**: 0001641172-25-013617

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250604

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250604

**DATE AS OF CHANGE**: 20250604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GLOBAL TECHNOLOGIES LTD
- **CENTRAL INDEX KEY:** 0000932021
- **STANDARD INDUSTRIAL CLASSIFICATION:** RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 860970492
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25668
- **FILM NUMBER:** 251023227

**BUSINESS ADDRESS:**
- **STREET 1:** 806 GREEN VALLEY ROAD
- **STREET 2:** SUITE 200
- **CITY:** GREENSBORO
- **STATE:** NC
- **ZIP:** 27408
- **BUSINESS PHONE:** (973) 233-5151

**MAIL ADDRESS:**
- **STREET 1:** 806 GREEN VALLEY ROAD
- **STREET 2:** SUITE 200
- **CITY:** GREENSBORO
- **STATE:** NC
- **ZIP:** 27408

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported) June 4, 2025

**Global Technologies, LTD**

(Exact name of registrant as specified in its charter)

Delaware 000-25668 86-0970492 <br> (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

806 Green Valley Road, Greensboro NC 27408 <br> (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code <u>(973) 233-5151</u>

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Class A Common Stock** | **GTLL** | **OTC Markets "PINK"** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 7.01 Regulation FD Disclosure**

On June 4, 2025, the Company issued a press release announcing Strategic Pivot and New Agreements in the health and wellness sector. A copy of the Company's press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Security Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits.**

(d) <u>Exhibits</u>

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| **99.1** | [Press Release Date June 4, 2025](ex99-1.htm) |
| **104** | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

**GLOBAL TECHNOLOGIES, LTD**

(Registrant)

Date <u>June 4,</u> <u>2025</u>

---

| |
|:---|
| */s/ H. Wyatt Flippen* |
| (Signature)\* |

---

## Exhibit 99.1

**Exhibit 99.1**

**Global Technologies, LTD Announces Strategic Pivot and New Agreements in Health & Wellness Sector**

**Greensboro, NC – June 4, 2025 – *Global Technologies, LTD* (OTCPK: GTLL),** a public, multi-operational company focused on innovation in health and wellness, recently announced corporate developments and commercial milestones signaling a bold pivot in strategy and leadership.

Over the past 90 days, GTLL has responded proactively to external FDA regulatory shifts that disrupted several industry sectors, including GLP-1 compounding and semaglutide supply. These changes catalyzed GTLL's sharpened focus on the digital health and wellness market, prompting operational streamlining and a commitment to scalable, revenue-focused platforms—particularly through its newly launched subsidiary, Primecare Supply, LLC.

**Launch of Primecare Supply and Execution of Key Agreements**

As disclosed in its May 30, 2025 Form 8-K filing, GTLL formally launched Primecare Supply, LLC and executed two transformative commercial agreements:

● On May 19, 2025, Primecare entered into a Revenue Share Agreement with a licensed pharmaceutical supplier. Under this structure, Primecare retains 75% of gross margin revenue above the supplier's floor price while supporting FDA-compliant sales and post-sale obligations to its network of wellness providers.

● On May 28, 2025, Primecare signed a Master Licensing Agreement with a specialized AI technology partner, gaining access to tools for digital ordering, compliance automation, CRM management, and real-time operational analytics. The platform fee is 2.5% of processed transactions, with a 24-month licensing term.

These agreements position Primecare—and GTLL—at the forefront of compliant pharmaceutical distribution and digital wellness innovation.

**Leadership Appointments and Strategic Realignment**

In line with the Company's refined strategy, H. Wyatt Flippen has been officially appointed Chairman of the Board in addition to his role as Chief Executive Officer. Concurrently, GTLL has removed the President of its clean energy subsidiary, GOe3, LLC, to allow for a full transition away from non-core operations in the EV sector.

*"We are building a business that's leaner, more focused, and directly aligned with FDA-compliant pharmaceutical distribution and digital wellness innovation,"* said Flippen. *"These agreements and leadership changes reflect our resolve to reduce complexity, expand into higher-growth sectors, and deliver long-term shareholder value."*

**A Clearer Path Ahead**

GTLL is aggressively expanding its offerings in consumer-facing wellness plans and therapeutic products, leveraging both traditional partnerships and digital infrastructure. The Company is now fully aligned around the growth of its Primecare platform and related ventures, with future announcements anticipated regarding new reseller relationships, patient outreach programs, and proprietary health technologies.

**About Global Technologies, LTD**

*Global Technologies, LTD* (OTCPK: GTLL) is a public, multi-operational company committed to building scalable businesses in digital health, wellness, and technology. Through acquisitions, strategic licensing, and integrated platforms, GTLL delivers innovative solutions to improve lives and expand shareholder value.

Forward Looking Statements:

Statements made in this press release that express the Company or management's intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will" and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company's future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. No information in this press release should be construed as any indication whatsoever of the Company's future revenues or results of operations.

Investor Contact:

Wyatt Flippen, CEO and Chairman of the Board<br> <u>W.Flippen@globaltechnologiesltd.info</u>